Trials / Unknown
UnknownNCT02353364
Blastocyst Euploidy Assessment and Conditioned embryO traNsfer
Prospective Randomised Control Trial of Blastocyst Euploidy Assessment and Conditioned Embryo Transfer for Infertility Patients of Advanced Maternal Age
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- Female
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to evaluate the effectiveness of pre-implantation genetic screening (PGS) for infertility patients of advanced maternal age undergoing assisted reproductive treatment. Half of the patients will have their embryos tested by PGS and 1 or 2 chromosomally normal embryos with the highest morphological grading transplanted back to the uterus. The other half of the participants will not have their embryos tested and 1 or 2 untested embryos with the highest morphological grading transplanted back to the uterus.
Detailed description
PGS is an assisted reproductive technology that screens patients embryos, discriminating between embryos with a normal set of chromosomes (euploid) and those with an abnormal set of chromosomes (aneuploid). In this study, we will apply a novel validated next generation sequencing technology called copy number variation sequencing (CNV-Seq) to comprehensively screen a trophectoderm biopsy sample from patient's embryos for chromosomal abnormalities that commonly arise in human embryos. The hypothesis is that PGS performed using CNV-Seq on embryos produced by patients with a poor prognosis for pregnancy (maternal age \> 35), followed by transfer of chromosomally normal euploid embryos, will result in significantly higher implantation, pregnancy and live birth rates and lower miscarriage rates compared to patients having no PGS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | PGS | Embryos screened by the validated NGS technology CNV-Seq |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-12-01
- Completion
- 2016-10-01
- First posted
- 2015-02-02
- Last updated
- 2015-02-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02353364. Inclusion in this directory is not an endorsement.